Literature DB >> 20071882

Antiretroviral treatment programmes in Nepal: Problems and barriers.

Sharada Prasad Wasti1, P Simkhada, E R Teijlingen.   

Abstract

BACKGROUND: Antiretroviral (ARV) drugs have become the cornerstone of HIV (Human Immunodeficiency Virus) care and treatment. Its use has led to a marked reduction in AIDS (Acquired Immune Deficiency Syndrome) related morbidity and mortality. However, more than fi ve years after their introduction few HIV infected people in Nepal are receiving ARVs.
OBJECTIVE: The main aim of this study is to identify barriers and obstacles to providing and expanding ARV programmes in Nepal.
MATERIALS AND METHODS: A qualitative approach consisting of in-depth interviews with three groups of stakeholders:policy makers, ARV service providers and ARV recipients were carried out. The transcripts were analysed using a thematic approach.
RESULTS: The estimated number of people in need was high compared with people currently receiving ARV in Nepal. With regards to the proper distribution of the ARVs, the main problems identified in the interviews were: lack of infrastructure, lack of human resources, financial constraints, programmatic problems, weak leadership and management at national level, poor cooperation between management structures, geographical barriers, lack of awareness and low uptake of counselling and/or testing, stigmatization and discrimination felt by the health workers and the community, lack of coordination and limited access to services.
CONCLUSION: Limited resources and administrative capacity coupled with strong underlying needs for services pose serious challenges to the government. Despite this, better use could be made of existing services and resources to help benefit more people from ARV.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20071882     DOI: 10.3126/kumj.v7i3.2743

Source DB:  PubMed          Journal:  Kathmandu Univ Med J (KUMJ)        ISSN: 1812-2027


  8 in total

1.  Factors associated with adherence to antiretroviral therapy in HIV-infected patients in Kathmandu District, Nepal.

Authors:  Rajesh Shigdel; Elise Klouman; Anita Bhandari; Luai A Ahmed
Journal:  HIV AIDS (Auckl)       Date:  2014-06-24

2.  Clinic Attendance for Antiretroviral Pills Pick-Up among HIV-Positive People in Nepal: Roles of Perceived Family Support and Associated Factors.

Authors:  Rakesh Ayer; Kimiyo Kikuchi; Mamata Ghimire; Akira Shibanuma; Madhab Raj Pant; Krishna C Poudel; Masamine Jimba
Journal:  PLoS One       Date:  2016-07-20       Impact factor: 3.240

3.  The economic burden of HIV/AIDS on individuals and households in Nepal: a quantitative study.

Authors:  Ak Narayan Poudel; David Newlands; Padam Simkhada
Journal:  BMC Health Serv Res       Date:  2017-01-24       Impact factor: 2.655

4.  Impact of a massive earthquake on adherence to antiretroviral therapy, mental health, and treatment failure among people living with HIV in Nepal.

Authors:  Bharat Singh Negi; Sunil Kumar Joshi; Minato Nakazawa; Tomohiro Kotaki; Anup Bastola; Masanori Kameoka
Journal:  PLoS One       Date:  2018-06-11       Impact factor: 3.240

5.  Barriers to and facilitators of antiretroviral therapy adherence in Nepal: a qualitative study.

Authors:  Sharada P Wasti; Padam Simkhada; Julian Randall; Jennifer V Freeman; Edwin van Teijlingen
Journal:  J Health Popul Nutr       Date:  2012-12       Impact factor: 2.000

6.  Survival on antiretroviral treatment among adult HIV-infected patients in Nepal: a retrospective cohort study in Far-western region, 2006-2011.

Authors:  Laxmi Bhatta; Elise Klouman; Keshab Deuba; Rachana Shrestha; Deepak Kumar Karki; Anna Mia Ekstrom; Luai Awad Ahmed
Journal:  BMC Infect Dis       Date:  2013-12-26       Impact factor: 3.090

7.  HIV/AIDS in the South-East Asia region: progress and challenges.

Authors:  Razia Pendse; Somya Gupta; Dongbao Yu; Swarup Sarkar
Journal:  J Virus Erad       Date:  2016-11-28

8.  Factors influencing adherence to antiretroviral treatment among adults accessing care from private health facilities in Malawi.

Authors:  Lusungu Chirambo; Martha Valeta; Tifiness Mary Banda Kamanga; Alinane Linda Nyondo-Mipando
Journal:  BMC Public Health       Date:  2019-10-28       Impact factor: 3.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.